<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9871878D-4564-419C-8FE6-9A275F08C1BD"><gtr:id>9871878D-4564-419C-8FE6-9A275F08C1BD</gtr:id><gtr:name>Rhythm Pharmaceuticals</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9871878D-4564-419C-8FE6-9A275F08C1BD"><gtr:id>9871878D-4564-419C-8FE6-9A275F08C1BD</gtr:id><gtr:name>Rhythm Pharmaceuticals</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/60F94A2A-4B83-4F9C-8F07-A4260DCE0450"><gtr:id>60F94A2A-4B83-4F9C-8F07-A4260DCE0450</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>O'Rahilly</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F480A28A-1B19-4797-ADD7-A7E1D402AC46"><gtr:id>F480A28A-1B19-4797-ADD7-A7E1D402AC46</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Coll</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5FB1E0BA-FEB5-48CA-A750-72009C384555"><gtr:id>5FB1E0BA-FEB5-48CA-A750-72009C384555</gtr:id><gtr:firstName>Sadaf</gtr:firstName><gtr:surname>Farooqi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/54F3BE51-B737-4176-A912-B7FD5348B5FD"><gtr:id>54F3BE51-B737-4176-A912-B7FD5348B5FD</gtr:id><gtr:firstName>Giles</gtr:firstName><gtr:surname>Yeo</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900554"><gtr:id>DFB5622F-98C2-4434-93C8-3D30E24D7AF6</gtr:id><gtr:title>Molecular and pathophysiological mechanisms in human obesity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900554</gtr:grantReference><gtr:abstractText>Obesity is an important medical problem as it can lead to early death from diabetes, heart attacks and strokes and also causes considerable chronic ill health and a lowered quality of life. While it is clear that the reasons behind the recent increase in the frequency of obesity in most populations must lie in changes in factors such as the availability, cost and quality of food and the reduction in the need for physical activity it is also important to ask why, in the face of these environmental factors some people stay slim while others gain weight. We know from studies of twins and adopted children that genetics is a very important factor in determining the risk of becoming obese. Indeed in some children with very severe obesity from a young age we have found mutations in single genes that are sufficient in themselves to result in the child?s obesity. In one case we have been able to completely cure obesity by replacing the ?broken? gene product. We study a group of ~3500 severely obese children and so far have found a single gene mutation causing obesity in about 10% of these. New techniques for finding disease genes are now available and we want to use a range of novel approaches to try to find the causes of obesity in the rest of these children. We hope that by knowing the cause we will be able to better target treatment. As well as the severe mutations that result in morbid obesity in children there are other more recently discovered subtle genetic variants each of which are common and alter a person?s weight by a few pounds. Some of these variants are in genes that were not expected to have an effect on body weight. We also plan to better understand how those genes contribute to body weight and whether manipulating them by drugs, diet or exercise might provide new approaches to treating obesity.</gtr:abstractText><gtr:technicalSummary>While the modern ?obesogenic environment is clearly driving secular trends in the prevalence of obesity, inter-individual differences in susceptibility to such influences are largely genetically determined. With MRC Programme grant support since 1999 we have developed a comprehensive programme of research into molecular and pathophysiological factors in human obesity, discovering several monogenic causes of severe, early-onset human obesity, utilizing the detailed study of such individuals to gain novel insights into control mechanisms underlying energy balance and other phenotypes in humans, and targeting therapy to genotypically defined subgroups. We have, more recently contributed to global efforts in discerning the set of more common genetic variants which underpin variation in adiposity across populations and are deeply engaged in attempts to understand the biology linking such variants to adiposity. 
In relation to severe early-onset obesity we propose i) To use targeted candidate gene analysis to discover and subsequently fully characterise novel, highly penetrant genetic causes of extreme early-onset obesity in three specific subphenotypes a) obesity with developmental delay b) obesity with neuroendocrine dysfunction c) obesity with disordered sleep/arousal ii) Having recently detected leptin receptor mutations in 2% of our GOOS cohort, to establish the contribution of such mutations to the obese phenotype and to exploit a series of naturally-occurring mutations to gain insights into structure/functional relationships within the leptin receptor iii) Having recently demonstrated a key role for the MC4R in the control of human blood pressure through the examination of MC4R haploinsufficient patients vs. matched equally obese controls to explore the longer term effects of MC4R deficiency on cardiovascular health.

In relation to the biology of common human obesity we propose i) To better understand the role of the gene (FTO) variants in which are most strongly associated with common human obesity, in the control of mammalian energy balance through studies in rodents and humans ii) To build on our recently reported discovery that FTO is a 2OG-dependent dioxygenase to understand the fundamental functions of FTO including its interactions with other proteins and its targets and how this relates to its physiological functions iii) To apply similar approaches to the understanding of the biology of other novel and highly validated obesity genes emerging from ongoing hypothesis-free approaches. 

We will bring a comprehensive, multidisciplinary approach to these problems using studies in vitro, in cellular systems, in rodent models and in humans.</gtr:technicalSummary><gtr:fund><gtr:end>2013-07-15</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2475249</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rhythm Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>sf Rhythm pharmaceuticals</gtr:description><gtr:id>CA3BCE7E-79EA-41B6-AD4B-7D7DDDA2593D</gtr:id><gtr:impact>phase 1 clinical trial will start in next few months</gtr:impact><gtr:outcomeId>KSsNQfwZ3eY-1</gtr:outcomeId><gtr:partnerContribution>Advised on development of a melanocortin agonist to treat obesity. The compound has been approved for phase 1 clinical trial. If sucessful, PI will lead a subsequent phase 2 trial</gtr:partnerContribution><gtr:piContribution>Advised on development of a melanocortin agonist to treat obesity. The compound has been approved for phase 1 clinical trial. If sucessful, PI will lead a subsequent phase 2 trial</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>SOR Doha talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>774897CC-BE80-4EE4-8111-F7820D4049DE</gtr:id><gtr:impact>Invited guest speaker at Academic Health System lecture series at Hamad Medical Corporation, Doha, Qatar

Raise awareness of research and IMS</gtr:impact><gtr:outcomeId>5460b9653f04d1.12083395</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Irish Medical News feature</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>484E78F0-5431-407A-A6D4-85274E350070</gtr:id><gtr:impact>Raised awareness of research and IMS

None</gtr:impact><gtr:outcomeId>U5xsjgx9pa5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.imn.ie/index.php?option=com_content&amp;view=article&amp;id=5418:arise-sir-orahilly&amp;catid=57:clinical-news&amp;Itemid=3</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Dublin Science Gallery</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F50159CE-DCCA-474E-8BCB-BF556D3F5C1E</gtr:id><gtr:impact>Invited speaker at Trinity College Dublin Science Gallery as part of exhibition and 'Lab in the Gallery' FAT LAB. The goal of FAT LAB is to initiate a widespread re-evaluation of the perception of fat by inviting visitors to the gallery to participate in real research experiments and by creating a series of talks and events to engage our target audience of 15-25 year olds.

Raise awareness of research and IMS</gtr:impact><gtr:outcomeId>5460a5e1322bb8.39577350</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://dublin.sciencegallery.com/video/2014/07/sciencefatstephenorahillyanddonaloshea</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR JCI Interview-Conversations with Giants in Medicine</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BADFE78E-24B6-4553-8DC7-C91AA7909547</gtr:id><gtr:impact>Raised awareness of research and IMS

None</gtr:impact><gtr:outcomeId>GLG6HL6wnA2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.jci.org/videos/cgms</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR University of Manchester talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F8192382-9049-41FC-98F3-56D282544A59</gtr:id><gtr:impact>Invited speaker at University of Manchester at Faculty's Life Science 'Leaders in Science' Lecture Series

Raise awareness of research and IMS</gtr:impact><gtr:outcomeId>5460b77195ef20.04324595</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR UCD MGA presentation lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1241417D-7861-4DD5-9D19-15853536263F</gtr:id><gtr:impact>Gave presentation when awarded Medical Graduates Association Distinguished Graduate Award from University College Dublin for 2014

Raised awareness of research and IMS</gtr:impact><gtr:outcomeId>5460a85a4bad91.26475848</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.ucd.ie/medicine/ourcommunity/ouralumni/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Pharmacology tea club talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>322DB875-718E-4A64-8A05-ABEB42E7B248</gtr:id><gtr:impact>Invited to give University of Cambridge Department of Pharmacology tea club talk

Raise awareness of research and of IMS</gtr:impact><gtr:outcomeId>5460a31a4d20c9.96036878</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR SAC Fondation Leducq</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>124E06CB-A142-4504-A9F2-A430EA98F230</gtr:id><gtr:impact>Scientific Advisory Committee

None</gtr:impact><gtr:outcomeId>PMUB6T7yXcV</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Award Lecture for Zulch prize</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F7053D39-57EA-490D-9313-9D562AC476C0</gtr:id><gtr:impact>Raised awareness of research and IMS

Prestigious award of Zulch prize</gtr:impact><gtr:outcomeId>54609d20255d95.87164935</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.mpg.de/8406171/zuelch_award_2014_orahilly_friedman</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR MedSOC talk, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>60C68218-241C-4A20-B176-1BD8B5F19393</gtr:id><gtr:impact>Invited speaker at MedSOC talk, University of Cambridge

Raise awareness of research and of IMS</gtr:impact><gtr:outcomeId>5460bafb35f4d9.07811435</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR MRC Centenary Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>173BE2D6-1AB7-4D37-8799-99FA39CDF2EA</gtr:id><gtr:impact>Raised awareness of research and IMS among public

None</gtr:impact><gtr:outcomeId>jubS3b81msh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR CSAR talk, University of Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B518B381-7B11-4D61-9C65-0155750BBE84</gtr:id><gtr:impact>Gave talk at Cambridge Society for the Application of Research on &amp;quot;Human Metabolic Disease, Lessons from the Extremes&amp;quot;

Raised awareness of research and of IMS</gtr:impact><gtr:outcomeId>5460a1d7b4c030.24843740</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.csar.org.uk/index.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Academy of Medical Sciences</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E3D42E80-0EFC-46EF-8463-924A70EDFD51</gtr:id><gtr:impact>Raised awareness of research and IMS

None</gtr:impact><gtr:outcomeId>W1YVyWiEeiy</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>sf Cheltenham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>59CC85DF-39F6-463E-82AD-27DB9FBA1563</gtr:id><gtr:impact>gave a public lecture at the Cheltenham Science Festival, stimulating questions and debate with the audience

Raised awareness and stimulated debate about the biological basis of obesity</gtr:impact><gtr:outcomeId>nLZmzEArNVM</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR RTE interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>888ACFE3-4C72-4979-884D-2BE4D16A64FE</gtr:id><gtr:impact>Raised awareness of research and IMS to the public

None</gtr:impact><gtr:outcomeId>jUrxBod2ZWR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>sor, science festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E9EBE1D4-4AC7-47DF-AC55-FACDF0A16E20</gtr:id><gtr:impact>public lecture to &amp;gt;300 people, at the Cambridge Science Festiva, March 2011

Several audience members visited the related display to learn more about the area</gtr:impact><gtr:outcomeId>GRm2KCBVGNR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR University of Bristol talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6BDEE58A-A69D-4E43-8E11-CD8F06AD155C</gtr:id><gtr:impact>Invited speaker at University of Bristol MRC IEU Seminar Series

Raise awareness of research and IMS</gtr:impact><gtr:outcomeId>5460ad01c523d0.98326421</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR National Health and Medical Research Council (NHMRC) CEO Obesity Roundtable</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>460FFAD5-9063-4341-B38E-D84DB698FECB</gtr:id><gtr:impact>Participated in roundtable discussion with members of Australian Government National Health and MRC and others

Raise awareness of research and IMS</gtr:impact><gtr:outcomeId>5460a7464c6ab5.77324604</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR University of Leuven</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9AF35EFE-2153-456F-BF1E-F881BF9E1280</gtr:id><gtr:impact>Gave talk at University of Leuven, Belgium in seminar series for high profile scientists aimed at broad audience

Raised awareness of research and IMS</gtr:impact><gtr:outcomeId>5460a0b5336504.07657933</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR CSaP</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0E2F12DF-4C63-4AD0-B783-0BFAA427205E</gtr:id><gtr:impact>Member of Centre for Science &amp;amp; Policy Executive Committee, University of Cambridge

None</gtr:impact><gtr:outcomeId>UsKsiHxFxyw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Research Lecture Karolinska Institute, Stockholm</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C7B5D5CE-159F-4A04-88F2-36C16300B9CC</gtr:id><gtr:impact>Raised awareness of research and IMS among peers

None</gtr:impact><gtr:outcomeId>SdqzNhVbkSR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Lancet article</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A2936973-4D76-4B73-AC49-3A1D7F76598C</gtr:id><gtr:impact>Raised awareness of research and IMS

None</gtr:impact><gtr:outcomeId>PqpF4iFg5xX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613616220.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>sf Dana Centre lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3EE0F59D-A05E-473A-9F56-B0E6F1FDE23C</gtr:id><gtr:impact>Evening lecture at the Dana Centre, followed by public debate with Sadaf Farooqi, University of Cambridge, Kevin Murphy, Imperial College London and Jane Landon, National Heart Forum
Event organised by the Global Medical Excellence Cluster

Stimulated a lively debate between lay audience and the speakers</gtr:impact><gtr:outcomeId>g6A3X7p7tpD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR, Galway Diabetes Research Centre</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CEB2FE02-30BE-46A4-8DEB-C3CE53991162</gtr:id><gtr:impact>http://www.conference.ie/Conferences/menu.asp?menu=1088&amp;amp;Conference=190

raised awareness of research are and IMS among peers</gtr:impact><gtr:outcomeId>MCG82n4QnUQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR University of the Third Age, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>643964AB-776D-44D1-970D-FE47C272D9BF</gtr:id><gtr:impact>Invited to give talk at University of the Third Age in Cambridge

Raise awareness of research and IMS</gtr:impact><gtr:outcomeId>5460b8a915b231.88197580</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>gy Group to encourage ethnic minority applications (GEEMA)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2A8D19C8-AFDD-4540-8AE9-6417BE86BA29</gtr:id><gtr:impact>Took part in a summer school for 40 15-year-olds from ethnic minorities to encourage applications to Cambridge University

Several students commented that they enjoyed meeting such a good role model, and were encouraged to apply to the University as a result. Ethnic minority applications are steadily increasing</gtr:impact><gtr:outcomeId>M5t89qdAN6h</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR BBC TV and Radio Interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BFCAA3EF-7486-4ACB-9800-637F5B873224</gtr:id><gtr:impact>Raise awareness of research and IMS to the public

None</gtr:impact><gtr:outcomeId>cVQcoYAtLUT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SOR Naked Scientist Question of the Week</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>45C4772D-2C06-4EB7-ACDF-019FABE740F0</gtr:id><gtr:impact>Raised awareness of research and IMS to public

None</gtr:impact><gtr:outcomeId>JrqQUYPknzg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.thenakedscientists.com/HTML/podcasts/qotw/show/20130307/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>6493079</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Research Centre</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>CFED4C1D-CD74-48AB-8145-1B1067AD463C</gtr:id><gtr:outcomeId>o7XkmhY8J6y</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>211500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>sf Neurofast</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>740ACCC1-4917-403C-9961-D716458E674A</gtr:id><gtr:outcomeId>Z1ix45ZHpZz0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30668</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>gy prader -w</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Foundation for Prader-Willi Research (FPWR)</gtr:fundingOrg><gtr:id>E84DCA53-BD4E-4ADB-8678-6A38B4C2F3A4</gtr:id><gtr:outcomeId>PPbn6dAPXS60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>28F8A8AA-111D-45DE-8793-FD7C98A121DB</gtr:id><gtr:title>Functional characterization of obesity-associated variants involving the a and ? isoforms of human SH2B1.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04805c136fdc80831b34653a2466319a"><gtr:id>04805c136fdc80831b34653a2466319a</gtr:id><gtr:otherNames>Pearce LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>5460d9f5690c44.44780439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1B3FE69-FAC6-4995-ADC9-DC430B66CDFB</gtr:id><gtr:title>Fat: an evolving issue.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc35efec60fbe5eb247f3e579d21a76b"><gtr:id>dc35efec60fbe5eb247f3e579d21a76b</gtr:id><gtr:otherNames>Speakman JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_12833_23_22915015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67D60C34-5AA4-4DBD-BDE1-2B5DF523D234</gtr:id><gtr:title>Obesity-associated melanocortin-4 receptor mutations are associated with changes in the brain response to food cues.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b999dc21fb790e84ec2195e9dceb37ba"><gtr:id>b999dc21fb790e84ec2195e9dceb37ba</gtr:id><gtr:otherNames>van der Klaauw AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>5460d9f51cc618.46692772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72AE4CB7-276D-40AC-BB0A-3F8C7B776AFA</gtr:id><gtr:title>Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency.</gtr:title><gtr:parentPublicationTitle>Molecular genetics and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b48d7941f44ce370fe3c533074bec08a"><gtr:id>b48d7941f44ce370fe3c533074bec08a</gtr:id><gtr:otherNames>Frank GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1096-7192</gtr:issn><gtr:outcomeId>pm_12833_23_23800642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C83480-AC8D-4A2E-A07E-B0B9A7DD7378</gtr:id><gtr:title>Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c22f2fd3aed31ccb55e23f785429963"><gtr:id>0c22f2fd3aed31ccb55e23f785429963</gtr:id><gtr:otherNames>Ziauddeen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_12833_23_23147384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>249D90C5-18E6-4491-80B1-A7657837E6C7</gtr:id><gtr:title>Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90eaab64ef82e6d388d056fda37c0027"><gtr:id>90eaab64ef82e6d388d056fda37c0027</gtr:id><gtr:otherNames>Speliotes EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>BSPsDNksTSk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A8B51D3-6C82-45D1-BC08-3C0C52C27CA1</gtr:id><gtr:title>Role for the obesity-related FTO gene in the cellular sensing of amino acids.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/741af3ae3e5d703b2f36eca95660ccaa"><gtr:id>741af3ae3e5d703b2f36eca95660ccaa</gtr:id><gtr:otherNames>Gulati P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_12669_29_23359686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9885B8C2-9967-4641-A761-01276E2DAF31</gtr:id><gtr:title>Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74ce9e920f79d168f3e85c2ba308bde7"><gtr:id>74ce9e920f79d168f3e85c2ba308bde7</gtr:id><gtr:otherNames>Martinelli CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>jcdeRq9Bdfy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49938B25-5C0C-4E4E-BFAD-31A192CB8390</gtr:id><gtr:title>Loss of agouti-related peptide does not significantly impact the phenotype of murine POMC deficiency.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29601a645e1aaed50e8d97e7ec77516"><gtr:id>a29601a645e1aaed50e8d97e7ec77516</gtr:id><gtr:otherNames>Corander MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>B05ED5B3_BB05ED5B3_B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36F52896-627B-407C-86A5-2A72AE99F867</gtr:id><gtr:title>Shedding pounds after going under the knife: guts over glory-why diets fail.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/019711b3dc8e62f04ea86c43440a77dc"><gtr:id>019711b3dc8e62f04ea86c43440a77dc</gtr:id><gtr:otherNames>Larder R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>pm_12833_23_22561823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F4D5880-F73B-4669-8CA7-3F958AF6E806</gtr:id><gtr:title>Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5199f9b15d112036e6d266d0a3dbea9b"><gtr:id>5199f9b15d112036e6d266d0a3dbea9b</gtr:id><gtr:otherNames>Fletcher PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>GAjezkuQfcW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0640A288-4484-4CDD-BEA2-7CCDA64680A9</gtr:id><gtr:title>Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6fc94b81087af593be7c12ea840dd53"><gtr:id>b6fc94b81087af593be7c12ea840dd53</gtr:id><gtr:otherNames>Ren? P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn><gtr:outcomeId>FTM5N8pwPR9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B73C79D9-FA3A-42E1-B680-22EE6DE6967C</gtr:id><gtr:title>20 years of leptin: human disorders of leptin action.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a92a770c3afb9f08de4d09f99c534177"><gtr:id>a92a770c3afb9f08de4d09f99c534177</gtr:id><gtr:otherNames>Farooqi IS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>5460d9f43df3b7.37212504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CC39395-EED5-4F60-964F-14604155867D</gtr:id><gtr:title>Insulin-like peptide 5 is an orexigenic gastrointestinal hormone.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4d87f10f47a5c90fc9c4fb919e5a4a4"><gtr:id>f4d87f10f47a5c90fc9c4fb919e5a4a4</gtr:id><gtr:otherNames>Grosse J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5460d9f545dec4.17869983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F90EF68F-438C-427A-A6E4-C03D40AD52B6</gtr:id><gtr:title>Kinetic analysis of FTO (fat mass and obesity-associated) reveals that it is unlikely to function as a sensor for 2-oxoglutarate.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/647f04fce88d423f200b199a6505db10"><gtr:id>647f04fce88d423f200b199a6505db10</gtr:id><gtr:otherNames>Ma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_12833_23_22435707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6375AF8-219C-459A-8883-7C54235309B8</gtr:id><gtr:title>Homozygosity for a novel missense mutation in the leptin receptor gene (P316T) in two Egyptian cousins with severe early onset obesity.</gtr:title><gtr:parentPublicationTitle>Molecular genetics and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54d688ce31f69b870a0fafdf97137738"><gtr:id>54d688ce31f69b870a0fafdf97137738</gtr:id><gtr:otherNames>Mazen I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1096-7192</gtr:issn><gtr:outcomeId>UFjricuM36s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>319BF46F-6952-42D2-999C-31087C5FCB98</gtr:id><gtr:title>Human SH2B1 mutations are associated with maladaptive behaviors and obesity.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/540b5800258d660efef9b4a9fceb4923"><gtr:id>540b5800258d660efef9b4a9fceb4923</gtr:id><gtr:otherNames>Doche ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm_12833_23_23160192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1695EDE8-E02E-4D24-943A-F9C1AA5B962F</gtr:id><gtr:title>Epidemiological evidence against a role for C-reactive protein causing leptin resistance.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a46d274f356317758b967d41c0b9dd2"><gtr:id>7a46d274f356317758b967d41c0b9dd2</gtr:id><gtr:otherNames>Rutter MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>pm_12833_23_23047304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEB1E6B0-59B4-4CAB-A4E8-716B1FE6B393</gtr:id><gtr:title>A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c76c446e6a2d372e762aff1c0ce3437"><gtr:id>9c76c446e6a2d372e762aff1c0ce3437</gtr:id><gtr:otherNames>Moreno-Navarrete JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_12833_23_23963324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>944CC11B-B9E5-4A04-838D-F80FD792A5DA</gtr:id><gtr:title>Erratum: Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects</gtr:title><gtr:parentPublicationTitle>Molecular Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c22f2fd3aed31ccb55e23f785429963"><gtr:id>0c22f2fd3aed31ccb55e23f785429963</gtr:id><gtr:otherNames>Ziauddeen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5460d9f3d76597.78033268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE2A5CF1-A48B-4157-A8FD-BC8F299BC435</gtr:id><gtr:title>FTO expression is regulated by availability of essential amino acids.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f872755043c99627af4d76d64be8042b"><gtr:id>f872755043c99627af4d76d64be8042b</gtr:id><gtr:otherNames>Cheung MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>pm_12833_23_22614055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE5969A9-0025-4A1D-9ED6-51CB42818607</gtr:id><gtr:title>A genome-wide association meta-analysis identifies new childhood obesity loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8a7063459223516acf5719facc6ab01"><gtr:id>a8a7063459223516acf5719facc6ab01</gtr:id><gtr:otherNames>Bradfield JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm-12833-22484627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AF1B97D-9A9D-4630-8D74-A5CA036E5F1A</gtr:id><gtr:title>Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc68d5cb206cac70047dbc415d056fd1"><gtr:id>fc68d5cb206cac70047dbc415d056fd1</gtr:id><gtr:otherNames>Wheeler E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_12833_23_23563609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6251F120-8BE2-4343-9960-0F2C3717913A</gtr:id><gtr:title>KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04805c136fdc80831b34653a2466319a"><gtr:id>04805c136fdc80831b34653a2466319a</gtr:id><gtr:otherNames>Pearce LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>5460d9f6554ce6.03708858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAF080F0-8757-473F-90A7-B66566A193B9</gtr:id><gtr:title>Genetic variance in the spinocerebellar ataxia type 2 (ATXN2) gene in children with severe early onset obesity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/997207b8a9a5cd3cc461d69e47f0eeda"><gtr:id>997207b8a9a5cd3cc461d69e47f0eeda</gtr:id><gtr:otherNames>Figueroa KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>aJTBHYCE53i</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5CE0311-B64D-480B-9B81-6865A027BFB8</gtr:id><gtr:title>Rare variants in single-minded 1 (SIM1) are associated with severe obesity.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f68bcec90d9765b68c50ba02267fdfd9"><gtr:id>f68bcec90d9765b68c50ba02267fdfd9</gtr:id><gtr:otherNames>Ramachandrappa S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm_12833_23_23778139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E3DDCAF-B034-47CF-9FB6-38B3FFC64B34</gtr:id><gtr:title>Depletion of stromal cells expressing fibroblast activation protein-a from skeletal muscle and bone marrow results in cachexia and anemia.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2524737715bbe7dbc29d3053ea6990ef"><gtr:id>2524737715bbe7dbc29d3053ea6990ef</gtr:id><gtr:otherNames>Roberts EW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_12669_29_23712428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D287839E-547C-43F8-B6CE-CCB21B3DA57C</gtr:id><gtr:title>CNS leptin action modulates immune response and survival in sepsis.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e4d9137bab55d1a68ac1f6441e79cb"><gtr:id>50e4d9137bab55d1a68ac1f6441e79cb</gtr:id><gtr:otherNames>Tsch?p J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>Mb6waaKdyqV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5A47B7B-00E6-4FB6-B932-59DD8398CBA4</gtr:id><gtr:title>Large, rare chromosomal deletions associated with severe early-onset obesity.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbf404e0147409ec4b5b4da04c070a38"><gtr:id>cbf404e0147409ec4b5b4da04c070a38</gtr:id><gtr:otherNames>Bochukova EG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>mxc5HCUoh3e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2B544C1-F780-4CB7-AB54-86D7DDB3E232</gtr:id><gtr:title>Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc35efec60fbe5eb247f3e579d21a76b"><gtr:id>dc35efec60fbe5eb247f3e579d21a76b</gtr:id><gtr:otherNames>Speakman JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_12833_23_22065844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53B4FD99-37D3-43A2-A56A-AA1342E9F12B</gtr:id><gtr:title>The biology of FTO: from nucleic acid demethylase to amino acid sensor.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/741af3ae3e5d703b2f36eca95660ccaa"><gtr:id>741af3ae3e5d703b2f36eca95660ccaa</gtr:id><gtr:otherNames>Gulati P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_12833_23_23896822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D2D9336-CDAC-4B8E-B52D-AFC2C48D14E9</gtr:id><gtr:title>Fat mass and obesity-related (FTO) shuttles between the nucleus and cytoplasm.</gtr:title><gtr:parentPublicationTitle>Bioscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/741af3ae3e5d703b2f36eca95660ccaa"><gtr:id>741af3ae3e5d703b2f36eca95660ccaa</gtr:id><gtr:otherNames>Gulati P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0144-8463</gtr:issn><gtr:outcomeId>5460d9f4140793.83295226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ECE797D-0017-4850-A83A-DE4BA9AF0766</gtr:id><gtr:title>&amp;quot;Are melanocortin receptors constitutively active in vivo?&amp;quot;.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>pm_12669_29_23872416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEF509FE-429D-4D02-AC34-E2FF43799C9A</gtr:id><gtr:title>Where to go with FTO?</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/019711b3dc8e62f04ea86c43440a77dc"><gtr:id>019711b3dc8e62f04ea86c43440a77dc</gtr:id><gtr:otherNames>Larder R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>pm_12669_29_21131211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>782C69C6-2E79-4BFF-A2B5-94C74E1547D8</gtr:id><gtr:title>A new highly penetrant form of obesity due to deletions on chromosome 16p11.2.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06f8745029723a356fd91c578b374879"><gtr:id>06f8745029723a356fd91c578b374879</gtr:id><gtr:otherNames>Walters RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>m3ut7rPnSp9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3655BC47-4F81-4FB4-BC5C-91204FD9806A</gtr:id><gtr:title>Adult onset global loss of the fto gene alters body composition and metabolism in the mouse.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b564dd3ccd7fd241b849ca353bc16ab6"><gtr:id>b564dd3ccd7fd241b849ca353bc16ab6</gtr:id><gtr:otherNames>McMurray F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_12669_29_23300482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>700C5187-B99B-4B1F-BA8B-CE91CBC4901A</gtr:id><gtr:title>Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31b001267788c1fe8377eaed30cfcf9c"><gtr:id>31b001267788c1fe8377eaed30cfcf9c</gtr:id><gtr:otherNames>Asai M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_12833_23_23869016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A970490-75B6-42FC-9407-56F034382391</gtr:id><gtr:title>The hypothalamus and metabolism: integrating signals to control energy and glucose homeostasis.</gtr:title><gtr:parentPublicationTitle>Current opinion in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-4892</gtr:issn><gtr:outcomeId>pm_12669_29_24075719</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900554</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>